Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs.

Harizi H, Limem I, Gualde N.

Immunol Cell Biol. 2011 Feb;89(2):275-82. doi: 10.1038/icb.2010.94. Epub 2010 Aug 10.

PMID:
20697426
2.

Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology.

Harizi H, Corcuff JB, Gualde N.

Trends Mol Med. 2008 Oct;14(10):461-9. doi: 10.1016/j.molmed.2008.08.005. Epub 2008 Sep 4. Review.

PMID:
18774339
3.

[Influenza, an eternal problem].

Barry S, Hessel L, Gualde N.

Can Bull Med Hist. 2007;24(2):445-66. French.

PMID:
18447314
4.

[The black death in Christian and Muslim Occident, 1347-1353].

Barry S, Gualde N.

Can Bull Med Hist. 2008;25(2):461-98. French.

PMID:
19297782
5.
6.
7.

Prostanoids and their receptors that modulate dendritic cell-mediated immunity.

Gualde N, Harizi H.

Immunol Cell Biol. 2004 Aug;82(4):353-60. Review.

PMID:
15283844
8.

Eicosanoids: an emerging role in dendritic cell biology.

Harizi H, Gualde N.

Arch Immunol Ther Exp (Warsz). 2004 Jan-Feb;52(1):1-5. Review.

PMID:
15053227
9.

Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes.

Harizi H, Grosset C, Gualde N.

J Leukoc Biol. 2003 Jun;73(6):756-63.

PMID:
12773508
11.

Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells.

Harizi H, Gualde N.

Prostaglandins Leukot Essent Fatty Acids. 2002 May-Jun;66(5-6):459-66.

PMID:
12144865
12.
13.

Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trial.

Ravaud A, Delaunay M, Chevreau C, Coulon V, Debled M, Bret-Dibat C, Courbon F, Gualde N, Nguyen Bui B.

Br J Cancer. 2001 Nov 16;85(10):1467-71.

14.

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.

Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ.

Psychoneuroendocrinology. 2001 Nov;26(8):797-808.

PMID:
11585680
15.

Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.

Harizi H, Juzan M, Grosset C, Rashedi M, Gualde N.

Cell Immunol. 2001 Apr 10;209(1):19-28.

PMID:
11414733
16.

Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.

Maes M, Capuron L, Ravaud A, Gualde N, Bosmans E, Egyed B, Dantzer R, Neveu PJ.

Neuropsychopharmacology. 2001 Feb;24(2):130-40.

17.

In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates.

Coulon V, Ravaud A, Gaston R, Delaunay M, Pariente JL, Verdier D, Scrivante V, Gualde N.

Int J Cancer. 2000 Dec 1;88(5):783-90.

18.

Renal synthesis of leukaemia inhibitory factor (LIF), under normal and inflammatory conditions.

Morel DS, Taupin JL, Potier M, Deminière C, Potaux L, Gualde N, Moreau JF.

Cytokine. 2000 Mar;12(3):265-71.

PMID:
10704254
20.

Sequential production of leukaemia inhibitory factor by blood cell culture in patients with ARDS.

Gruson D, Hilbert G, Juzan M, Taupin JL, Coulon V, Moreau JF, Gualde N, Gbikpi-Benissan G.

Intensive Care Med. 1998 Apr;24(4):366-8.

PMID:
9609417
21.

Effect of PGE2 on the cell surface molecule expression in PMA treated thymocytes.

Daculsi R, Vaillier D, Carron JC, Gualde N.

Immunol Lett. 1998 Feb;60(2-3):81-8.

PMID:
9557948
22.

Leukemia inhibitory factor: part of a large ingathering family.

Taupin JL, Pitard V, Dechanet J, Miossec V, Gualde N, Moreau JF.

Int Rev Immunol. 1998;16(3-4):397-426. Review.

PMID:
9505197
23.

Inhibition of graft-versus-host reaction by treatment of immature thymocytes with eicosanoids.

Juzan M, Guibert F, Gualde N.

Prostaglandins Leukot Essent Fatty Acids. 1998 Jan;58(1):69-75.

PMID:
9482169
24.

In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer.

Coulon V, Ravaud A, Huet S, Gualde N.

Hematol Cell Ther. 1997 Oct;39(5):237-44.

PMID:
9395898
25.

Refolding of soluble leukemia inhibitory factor receptor fusion protein (gp 190 sol DAF) from urea.

Liu H, Moreau JF, Gualde N, Fu J.

Mol Cell Biochem. 1997 Apr;169(1-2):43-50.

PMID:
9089630
26.

A monoclonal antibody based elisa for quantitation of human leukaemia inhibitory factor.

Taupin JL, Gualde N, Moreau JF.

Cytokine. 1997 Feb;9(2):112-8.

PMID:
9071562
27.

Heterogeneity of murine adherent interleukin-2-activated killer cells. Differential effect of prostaglandin E2 and forskolin.

Vaillier D, Daculsi R, Gualde N.

Cancer Immunol Immunother. 1995 Jan;40(1):65-71.

PMID:
7828169
28.
29.

Radiobiological features of acute myeloblastic leukemia: comparison of self-renewal versus terminally differentiated populations.

Cowen D, Richaud P, Landriau S, Lagarde P, Mahon FX, Baudet JJ, Belloc F, Gualde N, Reiffers J.

Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1133-40.

PMID:
7961022
30.
31.

Expression of the GST pi gene and response to tamoxifen therapy in locally advanced breast carcinomas.

Dorion-Bonnet F, Quénel N, Coindre JM, Mauriac L, Bonichon F, Durand M, Wafflart J, Moscow JA, Cowan KH, Gualde N.

Ann N Y Acad Sci. 1993 Nov 30;698:182-5. No abstract available.

PMID:
7904139
32.

Regulation by PGE2 of IL-2, IL-3 and IFN production by cortico-resistant thymocytes.

Daculsi R, Vaillier D, Gualde N.

Immunol Lett. 1993 Nov;38(3):229-35.

PMID:
7510266
33.

Functional characterization of liver-associated lymphocytes in patients with liver metastasis.

Winnock M, Garcia-Barcina M, Huet S, Bernard P, Saric J, Bioulac-Sage P, Gualde N, Balabaud C.

Gastroenterology. 1993 Oct;105(4):1152-8.

PMID:
7691673
34.

Immunogenicity of HILDA/LIF either in a soluble or in a membrane anchored form expressed in vivo by recombinant vaccinia viruses.

Taupin JL, Acres B, Dott K, Schmitt D, Kieny MP, Gualde N, Moreau JF.

Scand J Immunol. 1993 Sep;38(3):293-301.

PMID:
8356405
35.

Effect of PGE2 on thymocyte proliferation induced by Con A or IL-4 + PMA.

Daculsi R, Vaillier D, Bezian JH, Gualde N.

Int J Immunopharmacol. 1993 Feb;15(2):195-204.

PMID:
8385653
36.

NZB/NZW F1 mouse nephritis and immune response are not changed by treatment with a 15-lipoxygenase derivative.

Aldigier JC, Cook J, Delebassée S, Guibert F, Touchard G, Juzan M, Gualde N.

Prostaglandins Leukot Essent Fatty Acids. 1992 Oct;47(2):159-64.

PMID:
1461928
37.
38.

5-Lipoxygenase gene expression in the thymus.

Hostein I, Dorion-Bonnet F, Bloch B, Vaillier D, Juzan M, Gualde N.

Thymus. 1992 Sep;20(2):101-8.

PMID:
1519314
39.

Role of thymus-eicosanoids in the immune response.

Juzan M, Hostein I, Gualde N.

Prostaglandins Leukot Essent Fatty Acids. 1992 Aug;46(4):247-55. Review.

PMID:
1409761
40.

HILDA/LIF urinary excretion during acute kidney rejection.

Taupin JL, Morel D, Moreau JF, Gualde N, Potaux L, Bezian JH.

Transplantation. 1992 Mar;53(3):655-8.

PMID:
1549861
41.

Jacalin and artocarpin.

Preud'homme JL, Aucouturier P, Gualde N.

J Immunol Methods. 1992 Feb 5;146(2):259-63. No abstract available.

PMID:
1538148
42.

In vitro study of platelets and circulating mononuclear cells of subjects presenting an intolerance to aspirin.

Guez S, Gualde N, Bezian JH, Cabanieu G.

Int Arch Allergy Immunol. 1992;97(3):233-6.

PMID:
1587637
43.
44.

Effect of LTB4 on the inhibition of natural cytotoxic activity by PGE2.

Vaillier D, Daculsi R, Gualde N, Bezian JH.

Cell Immunol. 1992 Jan;139(1):248-58.

PMID:
1309490
45.
46.

Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome.

Jauberteau MO, Gualde N, Preud'Homme JL, Rigaud M, Gil R, Vallat JM, Baumann N.

Clin Exp Immunol. 1990 May;80(2):186-91.

47.

Purification and characterization of monoclonal antibodies to alpha-linolenic acid.

Buffière F, Cook-Moreau J, Gualde N, Rigaud M.

J Lipid Mediat. 1989 Mar-Apr;1(2):139-47.

PMID:
2485142
48.

Metabolic interactions between eicosanoids in blood and vascular cells.

Lagarde M, Gualde N, Rigaud M.

Biochem J. 1989 Jan 15;257(2):313-20. Review. No abstract available.

49.

Effect of arachidonic acid metabolites on CR1 expression by B-lymphocytes.

Cook JM, Guibert F, Delebassee S, Gualde N.

Int J Immunopharmacol. 1989;11(5):551-8.

PMID:
2553623
50.

A simple in vitro test to evaluate biocompatibility of dialysis membranes.

Vincent D, Charmes JP, Benzakour M, Gualde N, Rigaud M, Leroux-Robert C.

Nephrol Dial Transplant. 1989;4(4):306-8.

PMID:
2502740

Supplemental Content

Loading ...
Support Center